Pharma Pulse: The Provider Debate and Takeda’s $1.7 Billion AI Bet

Feb 11, 10:30 AM

Headliner
Share
Subscribe
In today’s Pharma Pulse, the American College of Physicians issues a formal rejection of the term "provider," while Takeda partners with Iambic Therapeutics to accelerate small-molecule discovery through AI.
Share
Subscribe
Next
Pharma Pulse: A Regulatory Standoff for mRNA Flu Shots and the Dual Power of GLP-1s
Top episodes
Overcoming Supply Chain Challenges
by Pharmaceutical Commerce
Incorporating AI into Commercialization Plans
by Pharmaceutical Commerce
The Capabilities of a 3PL Provider
by Pharmaceutical Commerce